BMO keeps USD 80.00 target for National Health Investors stock
Published on 10/15/2026 at 21:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and upcoming results
- BMO Capital maintained its USD 80.00 target for National Health Investors on October 14, 2026.
- Second-quarter revenue reached USD 121.32 million in 2026, versus USD 90.66 million a year earlier.
- National Health Investors stock costs EUR 58.75 at Lang & Schwarz on October 15, 2026 at 9:48 p.m. CEST.
- National Health Investors has a price-to-earnings ratio of 19.02 and a market capitalization of USD 3.2 billion.
BMO Capital maintained an USD 80.00 price target for National Health Investors on October 14, 2026, implying 21.56 percent upside from the USD 65.81 home-market quote. The analyst action gives investors a concrete valuation marker ahead of the company's next report. National Health Investors stock was trading at EUR 58.75 at Lang & Schwarz on October 15, 2026 at 9:48 p.m. CEST.
Second-quarter revenue reached USD 121.32 million
National Health Investors reported second-quarter 2026 revenue of USD 121.32 million, compared with USD 90.66 million in the year-earlier quarter. Net profit reached USD 55.67 million, up from USD 36.99 million, according to The Globe and Mail. The figures put operating scale ahead of the previous year's level, while the share price remains well below its 52-week high.
Price remains near the yearly low
The home-market quote was USD 65.81 on October 15, 2026 at 3:55 p.m. ET. NHI's 52-week range was USD 63.51 to USD 91.38, placing the stock USD 2.30 above its low and USD 25.57 below its high. The reported year-to-date performance was minus 14.50 percent, according to Simply Wall St.
Valuation meets a November 9 report date
National Health Investors had a market capitalization of USD 3.2 billion, a price-to-earnings ratio of 19.02 and a trailing dividend yield of 6.00 percent on October 15, 2026. PR Newswire reported that the company will release third-quarter 2026 results after the market closes on November 9, 2026, followed by a conference call on November 10, 2026.
Comparison with peers
NHI (NYSE, USD): plus 0.47 percent, P/E 19.02, market capitalization USD 3.2 billion
Healthpeak Properties (NYSE, USD): plus 1.15 percent, P/E 54.11, market capitalization USD 13.1 billion
Omega Healthcare Investors (NYSE, USD): plus 0.89 percent, P/E 16.24, market capitalization USD 13.8 billion
Trading closes with valuation in view
The combination of a USD 80.00 analyst target, a USD 3.2 billion market value and the November 9 reporting date gives the stock a defined set of reference points for the next trading phase. The quarterly figures also provide a direct comparison with the prior year.
National Health Investors stock was trading at EUR 58.75 at Lang & Schwarz on October 15, 2026 at 9:48 p.m. CEST.
The further course of trading is shown by the continuously updated real-time quote of National Health Investors stock.
National Health Investors market facts
- Company: National Health Investors, Inc.
- ISIN: US63633D1046
- Ticker: NHI
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 15, 2026, 9:48 p.m. CEST): EUR 58.75
- Market capitalization: USD 3.2 billion (as of October 15, 2026)
- 52-week range: USD 63.51-USD 91.38 (as of October 15, 2026)
- Sector / Industry: Real Estate / Healthcare Facilities REIT
Market context: Market report S&P 500.
